Lysyl Oxidase Like-4 (LOXL4) as a tumor marker and prognosticator in advanced stage laryngeal cancer.

Braz J Otorhinolaryngol · 2022 · PMC9615536 · PMID 33757755

Europe PMC DOI

hedged sentence

0.4560

closest p · 9.1× alpha

0.4560

boldest claim

The sentences

did not reach statistical significancep = 0.456not close (p > 0.1)

3.4 ± 0.38 [LOXL4 positive]) but this trend did not reach statistical significance ( p = 0.456) ( Fig. 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.